Harbour Capital Advisors, LLC

SEC CIK: 0001682501
Latest filing: Jul 15, 2026

SEC filings (opens in a new tab)

APLS holding history

Apellis Pharmaceuticals, Inc. in every 13F filed by Harbour Capital Advisors, LLC, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

APLS overview All 13F holders of APLS Full Q2 2026 holdings

Shares (Q1 2023): 0; Sold out in Q1 2023
Value: $0
% of portfolio: 0.0%
Quarters held: 2; Since Q3 2022

Holdings of APLS by Harbour Capital Advisors, LLC, by quarter
Quarter	Shares	Value	% of portfolio	Share change	Action	All holders
Q1 2023	0	$0	0.0%	−9,487−100.0%	Sold out	Holders
Q4 2022	9,487	$477.0K	0.2%	+2,717+40.1%	Added	Holders
Q3 2022	6,770	$392.0K	0.1%	+6,770	New	Holders